Drug Database
Back to search

Germany· DE-A57-4fd48edda5d4f27a

Deferoxaminmesilat Noridem Enterprises

A deferoxamine product containing deferoxamine mesilate, registered in Germany by Noridem Enterprises Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC V03AC01

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedDeferoxaminmesilat Noridem EnterprisesATCV03AC01REGISTER NO.DE-A57-4fd48edda5d4f2…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about deferoxamine mesilateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Deferoxamine is registered in 16 of 19 countries.

Countries holding a registration under ATC V03AC01 (deferoxamine), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 10 of them publish a price we can compare per daily dose
Search deferoxamine products by name

Deferoxamine · ATC V03AC01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deferoxamine costs, country by country.

Normalised to the WHO defined daily dose (2.8 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Deferoxamine · price per daily dose (2.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$48.38
  • FR France$33.66
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Deferoxamine Mesilate
Manufacturer
Noridem Enterprises Ltd
Country
Germany (DE)
ATC code
V03AC01
ATC class
Deferoxamine
Defined daily dose
2.8 g, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

49 interactions on record for deferoxamine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check deferoxamine against other medicinesHow interaction checks work

Deferoxamine · interactions on record

49 records

  • 9 severe
  • 5 moderate
  • 35 info

Most severe, free to view

  • CidofovirJ05AB12severe
  • VigabatrinN03AG04severe
  • InotersenN07XX15severe
  • IopamidolV08AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deferoxamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deferoxamine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Desferal
  • Belgium · Desferal
  • Bulgaria · Десферал
  • Cyprus · Deferoxamine Noridem
  • Czechia · Desferal
  • Denmark · Desferal
  • Spain · Desferin
  • Finland · Desferal
  • France · Desferal
  • United Kingdom (Northern Ireland) · Desferrioxamine Mesilate Noridem Enterprises
  • Greece · Deferoxamine Noridem, Demoferidon
  • Hungary · Desferal
  • Ireland · Desferal
  • Iceland · Desferal
  • Italy · Deferoxamina Noridem, Desferal
  • Luxembourg · Desferal
  • Netherlands · Desferal
  • Norway · Desferal
  • Poland · Desferal
  • Portugal · Desferal
  • Romania · Desferal
  • Sweden · Desferal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebf4c0da-2503-493e-a5cd-fa32e14e6acb
GET /v1/drugs/ebf4c0da-2503-493e-a5cd-fa32e14e6acb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intramuscular Use ,Intravenous Use ,Subcutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Deferoxamine Mesilate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about deferoxamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console